 CAMBRIDGE, Mass. and NEW YORK, Jan. 05, 2022 GLOBE NEWSWIRE -- Black Diamond Therapeutics, Inc. Nasdaq: BDTX, a precision oncology medicine company pioneering the discovery and development of MasterKey therapies, today announced that its President and Chief Executive Officer, David M. Epstein, Ph.D., will present an update on the Companys progress at the 40th Annual J.P. Morgan Healthcare Conference being held virtually on Wednesday, January 12, 2022 at 9:00 a.m. ET. 